TARDBP and amyotrophic lateral sclerosis: We have exploited this novel design in a proof‐of‐concept optical biosensing experiment and it proved to be highly effective in the detection of TDP‐43, a biomarker related to amyotrophic lateral sclerosis (ALS) and other neuropathies.